MedPath

A study of antibacterial activities and mechanism of action of Ha-Rak against common pathogenic bacteria in Thailand.

Phase 1
Conditions
Antibiotic&#45
resistant bacteria in Thailand.
Acinetobacter baumannii&#44
Pseudomonas aeruginosa&#44
Enterococcus spp.&#44
Escherichia coli&#44
Staphylococcus aureus&#44
Klebsiella pneumoniae&#44
Ha&#45
Rak&#44
Registration Number
TCTR20200731002
Lead Sponsor
Faculty of medicine siriraj hospital, Mahidol university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
30
Inclusion Criteria

1. Healthy volunteers.
2. 18 years old and older.
3. Have a body mass index (BMI) between 18-29 Kg/m2.
4. Consent to participate in the study voluntarily.

Exclusion Criteria

1. Having history of herbal medicine allergy.
2. Having a history of smoking, drinking alcohol, and/or alcoholic beverages of all kinds.
3. Pregnant or breastfeeding (in the case of female volunteers).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bacteria growth before and after taking medicine 30 mins. serumbactericidal activities, inflammatory cytokines, biofilm formations, antimicrobial peptides
Secondary Outcome Measures
NameTimeMethod
The safety of Ha-Rak in healthy volunteers. after taking medicine. side effects of Ha-Rak
© Copyright 2025. All Rights Reserved by MedPath